Prionics acquires CEDI-Diagnostics
Zurich, March 14, 2006 - Strategic partnership with world-famous life science innovation centre
Prionics announced the acquisition of CEDI-Diagnostics B.V. The Dutch firm is a spin-off from the world-famous Wageningen University and Research Centre (UR). Through the purchase of CEDI, Prionics will acquire a substantial number of new products and gain rights to commercialize developments made by the research centre. Prionics and Wageningen UR have additionally agreed on a strategic partnership for the development of future innovations in farm animal diagnostics.
With this acquisition, the successful Swiss company Prionics has accomplished several objectives. "We have acquired a firm with tests proven on the market and we gain access to future developments of a unique global research centre", says Dr Markus Moser, co-CEO of Prionics.
"The Animal Science Group of Wageningen UR, a recognized leader in the field of animal disease control, will contribute further potential for innovation to Prionics", comments Dr. Bruno Oesch, co-CEO and Head of Research & Development at Prionics AG.
The products made by CEDI include tests for the early diagnosis of foot and mouth disease or swine fever. "The CEDI products are excellent tests which make an ideal addition to our existing portfolio of farm animal diagnostics", says Ernst Zollinger, Head of Marketing & Sales at Prionics AG. And Dr. Gerrit Keizer, CEO of CEDI-Diagnostics ads: "The large complementarities of our companies will bring us additional future success.".
Terms of the agreement include that Wageningen UR will acquire a stake in Prionics. Further details are not disclosed.
|
Latest Media Release
Former Chief Veterinary Officer of Switzerland joins Prionics Board of Directors
(31.05.11)
